Title: The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy.
Journal: Oncology reports 20110601
Title: The insulin-like growth factor-1 receptor kinase inhibitor, NVP-ADW742, suppresses survival and resistance to chemotherapy in acute myeloid leukemia cells.
Journal: Oncology research 20100101
Title: [Progress in the studies on small molecule IGF-1R inhibitors].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20081001
Title: Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR).
Journal: Bioorganic & medicinal chemistry letters 20071001
Title: Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060601
Title: Medicinal chemistry approaches to target the kinase activity of IGF-1R.
Journal: IDrugs : the investigational drugs journal 20060601
Title: The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050215
